Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

CUSIP: 13471N300

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
3,838,602,439
Total 13F shares
904,884
Share change
+778,653
Total reported value
$950,122
Price per share
$1.05
Number of holders
15
Value change
+$805,185
Number of buys
7
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 13471N300?
CUSIP 13471N300 identifies CANF - Can-Fite BioPharma Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) as of Q2 2025

As of 30 Jun 2025, Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 904,884 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, RHUMBLINE ADVISERS, BNP PARIBAS FINANCIAL MARKETS, TWO SIGMA SECURITIES, LLC, CAPTRUST FINANCIAL ADVISORS, MORGAN STANLEY, UBS Group AG, FIFTH THIRD BANCORP, WELLS FARGO & COMPANY/MN, and Costello Asset Management, INC. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.